March 2, 2020 / 1:51 PM / a month ago

BRIEF-Eagle Pharma Reports Q4 Earnings Per Share Of $0.07

March 2 (Reuters) - Eagle Pharmaceuticals Inc:

* EAGLE PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS

* Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.48

* Q4 EARNINGS PER SHARE $0.07

* Q4 REVENUE $48.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $49.1 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $0.47 — REFINITIV IBES DATA

* ANTICIPATES STRONG 2020 GROWTH FOR TOTAL REVENUE AND GROSS PROFIT

* EAGLE PHARMACEUTICALS - RESEARCH AND DEVELOPMENT SPEND IN 2020, ON A NON-GAAP BASIS, IS EXPECTED TO BE $46-$50 MILLION

* EAGLE PHARMACEUTICALS - SG&A SPEND IN 2020, ON A NON-GAAP BASIS, IS EXPECTED TO BE $61-$64 MILLION, AS COMPARED TO $56.4 MILLION IN 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below